FT: Cinven aims to bring in over €1B in sale of French diagnostics firm


Cinven is looking to sell French diagnostics portfolio company Sebia and expects to receive over €1B in any deal, the FT reports.

Fellow private-equity firms and strategic buyers are seen making bids for Sebia which provides equipment for identifying diseases such as blood cancer.

Sebia's EBITDA has grown 10% a year since Cinven bought the company for €800M in 2010.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs